Navigation Links
Beacon Equity Issues Technical Trade Alerts on Drug Manufacturer Stocks: FRX, TEVA, AGN, CEPH, VRTX, ADLR
Date:2/26/2009

DALLAS, Feb. 26 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today.

Investors can view all of the daily trading notes for free by visiting: http://www.BeaconEquity.com/m

Today's Trade Alerts include: Forest Laboratories Inc. (NYSE: FRX), Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA), Allergan Inc. (NYSE: AGN), Cephalon Inc. (Nasdaq: CEPH), Vertex Pharmaceuticals Inc. (Nasdaq: VRTX) and Adolor Corp. (Nasdaq: ADLR).

Join the fastest growing investment community at: http://www.stockhideout.com

See what Cramer has to say about these stocks at: http://maddmoney.net/

BeaconEquity.com's Trade Alerts are brief analyses on the active stocks each day that are affecting the markets. These include breaking news, insider activity, recent 52-week highs/lows, technical breakouts, and other market driving information. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.

We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas by visiting: http://www.BeaconEquity.com/m

BeaconEquity.com is one of the industry's largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.BeaconEquity.com/m CRD# 2207572.

BeaconEquity.com Disclosure

BeaconEquity.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BeaconEquity.com is a wholly owned entity of BlueWave Advisors LLC, a financial public relations firm. Please read our report and visit our Web site, BeaconEquity.com, for complete risks and disclosures.

    Beacon Equity Research
    Jeff Bishop, (469)-252-3505
    press@beaconequity.com

David C. Masson of Beacon Equity Research is a member of the National Association of Securities Dealers, CRD number 2207572.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

JEFF BISHOP

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=70781


'/>"/>
SOURCE BeaconEquity.com
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. BioMagnetics Diagnostics Corp. Rated Speculative Buy, Target Price $1.42 by Beacon Equity Research
2. BeaconEquity.com Issues Trade Alerts on Biotechnology Stocks: ELN, PFE, AMGN, DNA, BIIB, GILD
3. Monogram Biosciences to Present at the ThinkEquity Partners Fifth Annual Growth Conference
4. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing
5. TorreyPines Therapeutics to Present at ThinkEquitys G5 Conference
6. ADVENTRX Pharmaceuticals to Present at the ThinkEquity Partners Fifth Annual Growth Conference
7. EntreMed to Present at ThinkEquity Partners 5th Annual Growth Conference
8. Luminex Corporation to Present at ThinkEquity Partners Investor Conference
9. TorreyPines Therapeutics to Present at ThinkEquitys ThinkClinic Conference
10. Lexicon Pharmaceuticals to Present at ThinkEquity ThinkClinic
11. Dendreon Secures $130 Million Committed Equity Financing Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb. 24, 2017 Provectus Biopharmaceuticals, ... the "Company"), a clinical-stage oncology and dermatology biopharmaceutical ... deadline to participate in its previously announced rights ... of shares of common stock and Series C ... of listed warrants. As previously ...
(Date:2/24/2017)... Cord Blood Corporation (NYSE: CO ) ("CCBC" ... collection, laboratory testing, hematopoietic stem cell processing and stem ... for the third quarter and first nine months of ... Third Quarter of Fiscal 2017 Highlights ... by 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... DIEGO , Feb. 24, 2017  OncoSec Medical ... cancer immunotherapies, will host a Key Opinion Leader event ... as an oral and poster presentation at the upcoming ... plan. The KOL event will be held in-person and ... PM EST / 9:00 AM PST at the Lotte ...
(Date:2/23/2017)... /PRNewswire/ - The Fight Against Cancer Innovation Trust (FACIT) ... pleased to report that Fusion Pharmaceuticals Inc. (Fusion) has ... Johnson Innovation – JJDC, Inc. (JJDC) as the lead ... Biotechnology Partners, and Genesys Capital, as well as founding ... ...
Breaking Biology Technology:
(Date:2/13/2017)... Feb. 13, 2017  RSA Conference -- RSA, a ... is designed to enhance fraud detection and investigation ... the RSA Fraud & Risk Intelligence Suite. The ... leverage additional insights from internal and external sources ... protect their customers from targeted cybercrime attacks. ...
(Date:2/8/2017)... 8, 2017 About Voice Recognition Biometrics Voice ... it against a stored voiceprint template. Acoustic features ... and tone are compared to distinguish between individual ... as most PCs already have a microphone and ... recognition biometrics are most likely to be deployed ...
(Date:2/8/2017)... LONDON , Feb. 7, 2017 Report ... $12.5 billion by 2021 from $8.3 billion in 2016 ... from 2016 to 2021. Report Includes - An ... of global market trends, with data from 2015 and ... through 2021. - Segmentation of the market on the ...
Breaking Biology News(10 mins):